Cambridge Investment Research Advisors
NEPH icon

Cambridge Investment Research Advisors’s Nephros NEPH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,149
Closed -$337K – 4027
2025
Q4 		$337K Buy
+69,149
New +$353K ﹤0.01% 3078

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Cornerstone Capital Palo Alto, California $1B AUM 21.47% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Cambridge Investment Research Advisors's NEPH Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Nephros (NEPH) in Q1 2026, closing a stake of 69,149 shares — an estimated $337K sold.

Cambridge Investment Research Advisors first reported a position in NEPH in Q4 2025 and held it in 1 quarter. The position peaked at $337K in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Nephros position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 69,149 Nephros shares in Q1 2026, an estimated $337K.
  • Cambridge Investment Research Advisors first reported a position in Nephros in Q4 2025 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Nephros position peaked at $337K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.